Back

Vagus nerve stimulation for chronic heart failure: differences in therapy delivery and clinical efficacy in ANTHEM-HF, INOVATE-HF, and NECTAR-HF

2 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Advanced heart failure Devices for Autonomic Modulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Imad Libbus

LivaNova USA, Inc., Houston (United States of America)

6 More presentations in this session

Presentation thumbnail
Professor G. Gambassi (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor D. Schoene (Gelsenkirchen, DE)
Abstract Slides
Presentation thumbnail
Professor M. Ciccone (Bari, IT)
Abstract Slides
Presentation thumbnail
Doctor C. Borrelli (Pisa, IT)
Abstract
Presentation thumbnail
Doctor R. Inciardi (Brescia, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Advanced heart failure

The Event

Event poster

ESC Congress 2019

2 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Favourable effect of transcutaneous vagus nerve stimulation on health-related quality of life in patients with heart failure and moderately reduced or preserved ejection fraction
thumbnail
Congress Presentation
Intravenous vagal nerve stimulation catheter minimizes left ventricular pressure-volume loop and myocardial oxygen consumption in a dog supported with percutaneous left ventricular assist device
thumbnail
Congress Presentation
Intravenous vagal stimulation catheter induces rapid heart rate reduction without hemodynamic compromise in a dog model of atrial fibrillation with severe tachycardia

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources